Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused M...( Drug Take-Back Network Launched by Pr...),Health

Drug Take-Back Network Launched by Product Stewardship Institute and King Pharmaceuticals

WASHINGTON, Dec. 5/PRNewswire-USNewswire/ -- The Product Stewardship Institute (PSI) convened its secondNational Pharmaceuticals Dialogue Meeting earlier this week in Washington, DC to discuss ways to improve the disposal of unused medications to combat increasing rates of prescription drug abuse, accidental poisonings, and environmental contamination. The meeting, sponsored by King Pharmaceuticals, Inc. (NYSE: KG), brought together more than 100 participants, including U.S. regulators from the Environmental Protection Agency (EPA), Food and Drug Administration (FDA), Department of Transportation (DOT), and Office of National Drug Control Policy (ONDCP), as well as state and local officials, industry groups, and advocacy organizations to share their expertise and insights on current legal and regulatory challenges facing drug disposal.

"As prescription drug abusers often obtain medications easily from the home of friends or family members, it is extremely important to address the safe and proper disposal of unused medication. King is committed to working together with leading stakeholders to come to a consensus on safe and effective drug disposal that will help to reduce the risk of drug abuse and environmental pollution in our communities," said Brian A. Markison, Chairman, President and Chief Executive Officer of King Pharmaceuticals. "We are pleased to be partnering with PSI in this important endeavor to improve public health."

In conjunction with this week's meeting, PSI and King launched the Drug Take-Back Network that establishes a central resource for information on drug take-back impediments and existing programs to collect and dispose of unused medications in communities around
'/>"/>